These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34258745)

  • 1. Covalent Antiviral Agents.
    Mirzaie S; Abdi F; GhavamiNejad A; Lu B; Wu XY
    Adv Exp Med Biol; 2021; 1322():285-312. PubMed ID: 34258745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review on the antiviral activities of chalcones.
    Elkhalifa D; Al-Hashimi I; Al Moustafa AE; Khalil A
    J Drug Target; 2021 Apr; 29(4):403-419. PubMed ID: 33232192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
    Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
    Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What clinicians need to know about antiviral drugs and viral resistance.
    Hodinka RL
    Infect Dis Clin North Am; 1997 Dec; 11(4):945-67. PubMed ID: 9421709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of resveratrol against emerging respiratory viral infections.
    Filardo S; Di Pietro M; Mastromarino P; Sessa R
    Pharmacol Ther; 2020 Oct; 214():107613. PubMed ID: 32562826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad-Spectrum Antiviral Agents Based on Multivalent Inhibitors of Viral Infectivity.
    Zelikin AN; Stellacci F
    Adv Healthc Mater; 2021 Mar; 10(6):e2001433. PubMed ID: 33491915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
    Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
    Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.
    Huang T; Sun L; Kang D; Poongavanam V; Liu X; Zhan P; Menéndez-Arias L
    Adv Exp Med Biol; 2021; 1322():219-260. PubMed ID: 34258743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target.
    Yuan S; Chu H; Huang J; Zhao X; Ye ZW; Lai PM; Wen L; Cai JP; Mo Y; Cao J; Liang R; Poon VK; Sze KH; Zhou J; To KK; Chen Z; Chen H; Jin DY; Chan JF; Yuen KY
    Sci Adv; 2020 Aug; 6(35):eaba7910. PubMed ID: 32923629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiviral potential of Phyllanthus species: a systematic review.
    Upadhyay R; Tiwari KN
    Arch Virol; 2023 Jun; 168(7):177. PubMed ID: 37310509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiviral drugs : Potent agents, promising therapies for COVID‑19 and therapeutic limitations].
    Malin JJ; Bunse T; Spinner CD; Protzer U
    Internist (Berl); 2022 Jan; 63(1):118-128. PubMed ID: 34988607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
    Jans DA; Wagstaff KM
    Cells; 2020 Sep; 9(9):. PubMed ID: 32942671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species as potential antiviral targets.
    Sander WJ; Fourie C; Sabiu S; O'Neill FH; Pohl CH; O'Neill HG
    Rev Med Virol; 2022 Jan; 32(1):e2240. PubMed ID: 33949029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
    Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antiviral resistance across acute and chronic viral infections.
    Mason S; Devincenzo JP; Toovey S; Wu JZ; Whitley RJ
    Antiviral Res; 2018 Oct; 158():103-112. PubMed ID: 30086337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral Drug Discovery To Address the COVID-19 Pandemic.
    Richman DD
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for the clinical development of antiviral therapies.
    Ng TI; Dorr PK; Krishnan P; Cohen DE; Rhee S; Wang SX; Ruzek MC; Mensa FJ; Kati WM
    Cytometry B Clin Cytom; 2021 Jan; 100(1):19-32. PubMed ID: 34542933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.